Streetbeat News

Regulatory

HSDT

Helius Medical Technologies has regained compliance with all applicable NASDAQ listing criteria, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 12:44 pm

PM

Philip Morris International Inc has filed for a potential two-part notes offering, according to an SEC filing.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:43 pm

SPY

Federal Reserve Governor Christopher Waller stated that recent data gives the Federal Reserve some breathing room before making the next rate decision. This suggests that the Fed may not rush to increase interest rates.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:43 pm

NVO

Novo Nordisk has launched its weight loss drug Wegovy in the UK, despite acknowledging ongoing supply constraints. The drug is available through the NHS weight management scheme and in the private market. The company is working to persuade European governments and insurers to reimburse Wegovy. In the US, Wegovy is priced at $1,350 per month, while in Europe, it retails for approximately €170-€300 per month. British insurers have indicated that they will not cover Wegovy under their policies.

Portfolio Pulse from Vandana Singh

September 05, 2023 | 12:36 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has ceased its opposition to the Right to Repair movement, which advocates for consumers' ability to repair their own devices. However, Author Services, a Scientology-owned organization, has voiced its opposition to the movement, citing concerns over unauthorized access to copyrighted works. The organization uses software locks on its electronic meter, which it claims could be circumvented if the Right to Repair legislation is passed.

Portfolio Pulse from Rounak Jain

September 05, 2023 | 12:34 pm

AKTX

Akari Therapeutics, Plc (NASDAQ:AKTX), a biotechnology company, has regained compliance with the Nasdaq minimum bid price requirement. The company received a notification from Nasdaq after its American Depository Shares (ADSs) had a closing bid price of $1.00 per share or greater for 10 consecutive business days.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:19 pm

PBLA

Panbela Therapeutics, Inc. (NASDAQ:PBLA) has announced the issuance of a new patent in Chile for its product Flynpovi, a fixed dose formulation of eflornithine and sulindac developed in collaboration with Sanofi. The patent, which is valid until 2036, has also been issued in the US, Australia, Mexico, and Taiwan. Flynpovi is Panbela's lead investigational product for the treatment of Familial Adenomatous Polyposis (FAP).

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:16 pm

CING

Cingulate Therapeutics has announced the presentation of full trial results from its Phase 3 adult efficacy and safety trial of CTx-1301 for ADHD at Psych Congress 2023.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 12:13 pm

CVKD

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is developing tecarfarin, a novel Vitamin K Antagonist, to prevent heart attacks, strokes, and deaths due to blood clots in patients with certain rare medical conditions. The company believes tecarfarin is the solution for an unmet need, as recent data from the European Society of Cardiology Congress revealed more bleeding complications when switching from VKA treatment to direct oral anticoagulants in frail older patients. Cadrenal's tecarfarin has orphan drug and Fast Track designations for the prevention of systemic thromboembolism in patients with ESKD and AFib, presenting a U.S. market opportunity in excess of $2 billion per year.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:12 pm

DATS

DatChat has filed a patent for a technology that allows secure access to group-based digital assets across its metaverse and social media platforms. The technology aims to provide users with control over their digital assets and privacy.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 12:09 pm